Clinical Trial Update: iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for iC9-GD2-CAR-VZV-CTLs in GD2-positive osteosarcoma and neuroblastoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma
• Osteosarcoma

Drugs mentioned

• iC9-GD2-CAR-VZV-CTLs

Snippet

Sponsor: Baylor College of Medicine | Conditions: Osteosarcoma, Neuroblastoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING